We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
126
Arcus Biosciences
RCUS
$3.59B
$403K 0.23%
26,389
+21,385
+427% +$337K
BEN icon
127
Franklin Resources
BEN
$16.9B
$402K 0.23%
+19,962
New +$430K
ATRC icon
128
AtriCure
ATRC
$1.75B
$400K 0.23%
+14,250
New +$351K
ATNI icon
129
ATN International
ATNI
$361M
$399K 0.23%
+12,349
New +$325K
FR icon
130
First Industrial Realty Trust
FR
$8.85B
$398K 0.23%
7,112
+3,422
+93% +$184K
BXC icon
131
BlueLinx
BXC
$455M
$397K 0.23%
+3,766
New +$385K
BPMC
132
DELISTED
Blueprint Medicines
BPMC
$397K 0.23%
4,287
+2,998
+233% +$298K
BLKB icon
133
Blackbaud
BLKB
$1.52B
$396K 0.23%
4,681
+3,773
+416% +$301K
EGBN icon
134
Eagle Bancorp
EGBN
$868M
$394K 0.22%
17,451
+11,685
+203% +$245K
POWI icon
135
Power Integrations
POWI
$3.57B
$393K 0.22%
+6,136
New +$405K
LKQ icon
136
LKQ Corp
LKQ
$6.56B
$393K 0.22%
9,849
+8,753
+799% +$361K
CVBF icon
137
CVB Financial
CVBF
$3.97B
$393K 0.22%
+22,047
New +$393K
FCX icon
138
Freeport-McMoran
FCX
$89.5B
$391K 0.22%
+7,842
New +$353K
WWW icon
139
Wolverine World Wide
WWW
$1.54B
$390K 0.22%
+22,394
New +$310K
WGS icon
140
GeneDx Holdings
WGS
$1.8B
$390K 0.22%
9,188
+4,118
+81% +$139K
CX icon
141
Cemex
CX
$17.5B
$388K 0.22%
63,531
+55,060
+650% +$346K
CDNA icon
142
CareDx
CDNA
$1.93B
$385K 0.22%
12,340
+8,813
+250% +$219K
AAP icon
143
Advance Auto Parts
AAP
$3.35B
$385K 0.22%
9,878
+9,513
+2,606% +$504K
CROX icon
144
Crocs
CROX
$6.73B
$385K 0.22%
2,656
+2,234
+529% +$305K
DGII icon
145
Digi International
DGII
$2.51B
$383K 0.22%
+13,914
New +$367K
BA icon
146
Boeing
BA
$166B
$382K 0.22%
+2,513
New +$431K
BMI icon
147
Badger Meter
BMI
$3.68B
$381K 0.22%
+1,745
New +$350K
ENSG icon
148
The Ensign Group
ENSG
$10.1B
$381K 0.22%
+2,647
New +$377K
OTIS icon
149
Otis Worldwide
OTIS
$27.7B
$380K 0.22%
+3,658
New +$349K
VITL icon
150
Vital Farms
VITL
$551M
$379K 0.22%
+10,801
New +$382K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.